drugset / Trial / NCT00998608

Comparison of the Efficacy and Safety of Risperidone Versus Risperidone Plus Low Dose of Haloperidol in the Treatment of Schizophrenia

NCT00998608

Phase 4 Terminated 88 enrolled Kaohsiung Kai-Suan Psychiatric Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to compare the efficacy and safety of risperidone and risperidone plus low dose of haloperidol in the acutely schizophrenic patients.

Timeline

Start
2007-08
Primary completion
2009-07
Completion
2009-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Risperidone Other / unclassified 4 mg

Indications